MediivaHealth is building a scalable, multi-spectral photonic platform designed to enable next-generation non-invasive biochemical and hemodynamic assessment architectures.
Drishti-Bio is a laboratory-stage photonic sensing platform integrating multi-spectral optical emission, signal modeling and hemodynamic gating architecture.
The core objective is to establish a scalable non-invasive biochemical signal acquisition framework capable of replacing invasive sampling pathways in the long term.
Prototype validation and signal modeling are currently in controlled laboratory phase.
Over-reliance on invasive diagnostics limits accessibility in decentralized healthcare systems.
Recent progress in optical miniaturization and computational modeling enables new diagnostic architectures.
Alpha architecture development and foundational signal modeling under controlled laboratory conditions.
Test licensing, ethics approvals, ISO 13485 implementation and structured compliance alignment.
Controlled pilot and pivotal studies, IEC 60601 validation and regulatory submission.
Device calibration, manufacturing refinement and scalable market entry strategy.
MEDIIVAHEALTH PRIVATE LIMITED
PoleStar CoWorking Space, 3rd Floor,
Vijayanagar, Bangalore - 560040,
Karnataka, India
Email: info@mediivahealth.in
WhatsApp: +91 7019517775